{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T14:10:03Z","timestamp":1730643003602,"version":"3.28.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,3]]},"DOI":"10.7759\/cureus.72918","type":"journal-article","created":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T13:48:11Z","timestamp":1730641691000},"source":"Crossref","is-referenced-by-count":0,"title":["Golimumab-Induced Anti-NuMA-1 (Nuclear Mitotic Apparatus Protein 1) Antibodies in a Rheumatoid Arthritis Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Imane","family":"Bensaghir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latifa","family":"Tahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yassine","family":"Taoufik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanan","family":"Rkain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadoua","family":"Allali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198109173051223","article-title":"A unique antinuclear antibody staining only the mitotic-spindle apparatus","volume":"305","author":"McCarty GA","year":"1981","unstructured":"McCarty GA, Valencia DW, Fritzler MJ, Barada FA. A unique antinuclear antibody staining only the mitotic-spindle apparatus. N Engl J Med. 1981, 305:703. 10.1056\/NEJM198109173051223","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.116.6.1395","article-title":"Primary structure of NuMA, an intranuclear protein that defines a novel pathway for segregation of proteins at mitosis","volume":"116","author":"Compton DA","year":"1992","unstructured":"Compton DA, Szilak I, Cleveland DW. Primary structure of NuMA, an intranuclear protein that defines a novel pathway for segregation of proteins at mitosis. J Cell Biol. 1992, 116:1395-408. 10.1083\/jcb.116.6.1395","journal-title":"J Cell Biol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0029(20000601)49:5<467::AID-JEMT9>3.0.CO;2-V","article-title":"NuMA: a nuclear protein involved in mitotic centrosome function","volume":"49","author":"Zeng C","year":"2000","unstructured":"Zeng C. NuMA: a nuclear protein involved in mitotic centrosome function. Microsc Res Tech. 2000, 49:467-77. 10.1002\/(SICI)1097-0029(20000601)49:5&lt;467::AID-JEMT9&gt;3.0.CO;2-V","journal-title":"Microsc Res Tech"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1242\/jcs.01568","article-title":"Multiple mechanisms regulate NuMA dynamics at spindle poles","volume":"117","author":"Kisurina-Evgenieva O","year":"2004","unstructured":"Kisurina-Evgenieva O, Mack G, Du Q, Macara I, Khodjakov A, Compton DA. Multiple mechanisms regulate NuMA dynamics at spindle poles. J Cell Sci. 2004, 117:6391-400. 10.1242\/jcs.01568","journal-title":"J Cell Sci"},{"key":"ref5","article-title":"","author":"Bradwell AR","year":"2003","unstructured":"Bradwell AR, Hughes RG, Harden EL. Atlas of HEp-2 Patterns and Laboratory Techniques. Binding Site, Birmingham; 2003. https:\/\/books.google.co.ma\/books?id=24XpPAAACAAJ."},{"key":"ref6","article-title":"Clinical association of antinuclear antibodies (ANA) anti-NuMA1 and anti- NuMA2 (anti-HsEg5) in Patients with autoimmune and cardiovascular disease","volume":"2","author":"Maria Elena Soto ME","year":"2019","unstructured":"Maria Elena Soto ME, Becerril NH, R\u00edos GR, et al.. Clinical association of antinuclear antibodies (ANA) anti-NuMA1 and anti- NuMA2 (anti-HsEg5) in Patients with autoimmune and cardiovascular disease. J Clin Chem Lab Med. 2019, 2:118.","journal-title":"J Clin Chem Lab Med"},{"key":"ref7","article-title":"Significato clinico dei quadri fluoroscopici specifici per il fuso mitotico in pazienti affetti da malattie reumatiche","volume":"54","author":"Grypiotis P","year":"2002","unstructured":"Grypiotis P, Ruffatti A, Tonello M, et al.. Significato clinico dei quadri fluoroscopici specifici per il fuso mitotico in pazienti affetti da malattie reumatiche. Reumatismo. 2002, 54:232-7.","journal-title":"Reumatismo"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-9038-y","article-title":"Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance","volume":"26","author":"Bonaci-Nikolic B","year":"2006","unstructured":"Bonaci-Nikolic B, Andrejevic S, Bukilica M, Urosevic I, Nikolic M. Autoantibodies to mitotic apparatus: association with other autoantibodies and their clinical significance. J Clin Immunol. 2006, 26:438-46. 10.1007\/s10875-006-9038-y","journal-title":"J Clin Immunol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-008-9170-y","article-title":"Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies","volume":"28","author":"Mozo L","year":"2008","unstructured":"Mozo L, Guti\u00e9rrez C, G\u00f3mez J. Antibodies to mitotic spindle apparatus: clinical significance of NuMA and HsEg5 autoantibodies. J Clin Immunol. 2008, 28:285-90. 10.1007\/s10875-008-9170-y","journal-title":"J Clin Immunol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/0090-1229(85)90045-5","article-title":"Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A\/Ro) antibodies in female blood donors","volume":"36","author":"Fritzler MJ","year":"1985","unstructured":"Fritzler MJ, Pauls JD, Kinsella TD, Bowen TJ. Antinuclear, anticytoplasmic, and anti-Sjogren's syndrome antigen A (SS-A\/Ro) antibodies in female blood donors. Clin Immunol Immunopathol. 1985, 36:120-8. 10.1016\/0090-1229(85)90045-5","journal-title":"Clin Immunol Immunopathol"},{"key":"ref11","article-title":"Epidemiology and clinical associations of NuMA (nuclear mitotic apparatus protein) autoantibodies","volume":"21","author":"Auer-Grumbach P","year":"1994","unstructured":"Auer-Grumbach P, Achleitner B. Epidemiology and clinical associations of NuMA (nuclear mitotic apparatus protein) autoantibodies. J Rheumatol. 1994, 21:1779-81.","journal-title":"J Rheumatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa881","article-title":"Anti-NuMA antibodies: clinical associations and significance in patients with primary Sj\u00f6gren's syndrome or systemic lupus erythematosus","volume":"60","author":"Arcani R","year":"2021","unstructured":"Arcani R, Bertin D, Bardin N, et al.. Anti-NuMA antibodies: clinical associations and significance in patients with primary Sj\u00f6gren's syndrome or systemic lupus erythematosus. Rheumatology (Oxford). 2021, 60:4074-84. 10.1093\/rheumatology\/keaa881","journal-title":"Rheumatology (Oxford)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2381::AID-ANR1>3.0.CO;2-M","article-title":"Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies","volume":"43","author":"Pisetsky DS","year":"2000","unstructured":"Pisetsky DS. Tumor necrosis factor alpha blockers and the induction of anti-DNA autoantibodies. Arthritis Rheum. 2000, 43:2381-2. 10.1002\/1529-0131(200011)43:11&lt;2381::AID-ANR1&gt;3.0.CO;2-M","journal-title":"Arthritis Rheum"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200011)43:11<2383::AID-ANR2>3.0.CO;2-D","article-title":"Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials","volume":"43","author":"Charles PJ","year":"2000","unstructured":"Charles PJ, Smeenk RJ, De Jong J, Feldmann M, Maini RN. Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials. Arthritis Rheum. 2000, 43:2383-90. 10.1002\/1529-0131(200011)43:11&lt;2383::AID-ANR2&gt;3.0.CO;2-D","journal-title":"Arthritis Rheum"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2036.2005.02576.x","article-title":"Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study","volume":"22","author":"Atzeni F","year":"2005","unstructured":"Atzeni F, Ardizzone S, Sarzi-Puttini P, et al.. Autoantibody profile during short-term infliximab treatment for Crohn's disease: a prospective cohort study. Aliment Pharmacol Ther. 2005, 22:453-61. 10.1111\/j.1365-2036.2005.02576.x","journal-title":"Aliment Pharmacol Ther"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(03)00701-7","article-title":"Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study","volume":"125","author":"Vermeire S","year":"2003","unstructured":"Vermeire S, Noman M, Van Assche G, et al.. Autoimmunity associated with anti-tumor necrosis factor alpha treatment in Crohn's disease: a prospective cohort study. Gastroenterology. 2003, 125:32-9. 10.1016\/s0016-5085(03)00701-7","journal-title":"Gastroenterology"},{"key":"ref17","article-title":"Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab","volume":"22","author":"Allanore Y","year":"2004","unstructured":"Allanore Y, Sellam J, Batteux F, Job Deslandre C, Weill B, Kahan A. Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab. Clin Exp Rheumatol. 2004, 22:756-8.","journal-title":"Clin Exp Rheumatol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/art.10876","article-title":"Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy","volume":"48","author":"De Rycke L","year":"2003","unstructured":"De Rycke L, Kruithof E, Van Damme N, et al.. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. Arthritis Rheum. 2003, 48:1015-23. 10.1002\/art.10876","journal-title":"Arthritis Rheum"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/310158-golimumab-induced-anti-numa-1-nuclear-mitotic-apparatus-protein-1-antibodies-in-a-rheumatoid-arthritis-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,3]],"date-time":"2024-11-03T13:48:12Z","timestamp":1730641692000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/310158-golimumab-induced-anti-numa-1-nuclear-mitotic-apparatus-protein-1-antibodies-in-a-rheumatoid-arthritis-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,3]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.72918","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,3]]}}}